Synthesis of sterically hindered 3,5,5-trimethyl 2,6-dioxo tetrahydro pyrimidine as HCV protease inhibitors

Tetrahedron Letters

Volumn 51, Issue 9, 2010, Pages 1276-1279

  Nair, Latha G ^a   Bogen, Stephane ^a   Doll, Ronald J ^a   Shih, N Y ^a   Njoroge, F George ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5,5 TRIMETHYL 2,6 DIOXO TETRAHYDROPYRIMIDINE; AMINE; NONSTRUCTURAL PROTEIN 3; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

HEPATITIS C VIRUS;

EID: 74749107591     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2009.12.129     Document Type: Article

References (42)

1. Carrera Jr. G.M., and Garvey D.S. J. Heterocycl. Chem. 29 (1992) 847
2. Coudert P., Rubar C., Couguelet J.M., Bastide J., and Bastide P. Pharm. Acta Helv. 66 (1991) 155
3. Otter B.A., Sasson I.M., and Gagnier R.P. J. Org. Chem. 47 (1982) 508
4. A number of patents describing hydantoins in general are published in various therapeutic area. One representative example is given by, Barney, D.; Beckenridge, R.; Neumann, P.; Shapiro, G.; Seiler, M. P.; Troxler, T. J. WO 01/85718 A1, 2001, pp 20.
5. DeWitt S.H., Kiely J.S., Stankovic M.C., Shroeder D.M., Reynolds C., and Pavia M.R. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6909
6. Dressman B.A., Spangle L.A., and Kaldor S.W. Tetrahedron Lett. 37 (1996) 937
7. DeWitt S.H., and Czarnik A.W. Acc. Chem. Res. 29 (1996) 114
8. Lau, J.; Bloch, P. Fourth International Symposium on Innovation and Perspective in Solid Phase Synthesis and Combinatorial Chemical Libraries, September, 1995, Edinburg, Scotland, UK.
9. Ben-Ishai D., Altman J., and Bernstein Z. Tetrahedron 33 (1977) 1191
10. Poje N., and Poje M. Tetrahedron Lett. 36 (1995) 8885
11. Hanessian S., Sanceau J.-Y., and Chemla P. Tetrahedron 51 (1995) 6669
12. Hanessian S., and Yang R.-Y. Tetrahedron Lett. 37 (1996) 5835
13. Matthews J., and Rivero R.A. J. Org. Chem. 62 (1997) 6090
14. Scicinski J., Barker M.D., Murray P.J., and Jarvie E.M. Bioorg. Med. Chem. Lett. 8 (1998) 3609
15. Funk C., Merrit A.J., and Ehrlich A. Arch. Biochem. Biophys. 35 (1952) 468
16. Fink K., Henderson R.B., and Fink R.M. J. Biol. Chem. 221 (1956) 425
17. Canellakis E.S. J. Biol. Chem. 221 (1956) 315
18. Fritzson P., and Pihl A. J. Biol. Chem. 226 (1957) 229
19. Caravica J., and Grisolia S. J. Biol. Chem. 231 (1958) 357
20. Philippi E., Hendgen F., and Hernler F. Monatsh 69 (1936) 270
21. Zhee-Cheng K.-Y., Robins R.K., and Cheng C.C. J. Org. Chem. 26 (1961) 1877
22. Dalmer, O.; Diehl, C.; Pieper, H. Ger Patent 606, 1934, 349.
23. Kim D.-K., Kim H.-T., Lim J., Gam J., Kim Y.-W., and Kim K.H. J. Heterocycl. Chem. (1996) 885
24. Ahmed S., Lofthouse R., and Shaw G. J. Chem. Soc., Perkin Trans. Org. Bioorg. 18 (1976) 1969
25. Fassihi A., Velazquez C., and Knaus E.E. J. Heterocycl. Chem. (2004) 263
26. Saladino R., Bernini R., Crestini C., Mincione E., Bergamini A., Marini S., and Palamara A.T. Tetrahedron 51 (1995) 7561
27. Smissman E.E., Matuszak A.J., and Corder C.N. J. Pharm. Sci. 53 (1964) 1541
28. Matthias, S.; Hans, R. G. U.S. Patent, 1966, US 3294800, p 1.
29. Chen K.X., Nair L., Vibulbhan B., Yang W., Arasappan A., Bogen S.L., Venkatraman S., Bennett F., Pan W., Blackman M.L., Padilla A.I., Prongay A., Cheng K.-C., Tong X., Shih N.-Y., and Njoroge F.G. J. Med. Chem. 52 (2009) 1370
30. Bracher F., and Papke T. J. Chem. Soc., Perkin. Trans. 1 18 (1995) 2323
31. 3) δ 168.99, 162.19, 156.11, 78.39, 57.69, 42.94, 41.12, 36.48, 35.91, 35.37, 33.79, 31.59, 31.42, 28.41, 26.38, 26.18.
32. Nair L., Sannigrahi M., Pinto P., Bogen S.L., Prongay A., Saksena A., Girijavallabhan V., Cheng K.-C., Tong X., Shih N.-Y., and Njoroge F.G. Bioorg. Med. Chem. Lett. 20 (2010) 567
33. Zhang R., and Madalengoitia J.S. J. Org. Chem. 64 (1999) 330
34. Chen K.X., Arasappan A., Njoroge F.G., Vibulbhan B., Buevich A., Chan T.-M., and Girijavallabhan V. J. Org. Chem. 67 (2002) 2730
35. Arasappan A., Chen K.X., Njoroge F.G., Parekh T.N., and Girijavallabhan V. J. Org. Chem. 67 (2002) 3923
36. For Boceprevir:. Venkatraman S., Bogen S., Arasappan A., Bennet F., Chen K., Jao E., Liu Y.-T., Lovey R., Hendreta S., Huang Y., Pan W., Parekh T., Pinto P., Popov V., Pike R., Ruan S., Santhanam B., Vibulbhan B., Wu W., Yang W., Kong J., Liang X., Wong J., Liu R., Butkiewicz N., Chase R., Hart A., Agrawal S., Ingravallo P., Pichardo J., Kong R., Baroudy B., Malcolm B., Guo Z., Prongay A., Madison V., Broske L., Cui X., Cheng K.-C., Hsieh T.Y., Brisson J.-M., Prelusky D., Korfmacher W., White R., Bogdanowich-Knipp S., Pavlovsky A., Bradley P., Saksena A.K., Ganguly A., Piwinski J., Girijavallabhan V., and Njoroge F.G. J. Med. Chem. 49 (2006) 6074
37. Zhang R., Beyer B.M., Durkin J., Ingram R., Njoroge F.G., Windsor W.T., and Malcolm B.A. Anal. Biochem. 270 (1999) 268
38. Taremi S.S., Beyer B., Maher M., Yao N., Prosise W., Weber P.C., and Malcolm B.A. Protein Sci. 7 (1998) 2143
39. * and discussions, see: J. F. Morrison, C. Walsh, in: A. Meister (Ed.), Adv. Enzymol., 1988, 61, 201.
40. Chung v., Carroll A.R., Gray N.M., Parry N.R., Thommes P.A., Viner K.C., and D'Souza E.A. Antimicrob. Agents Chemother. 49 (2005) 1381
41. Blight K.J., Kolykhalov A.A., and Rice C.M. Science 290 (2000) 1972
42. Lohmann V., Körner F., Koch J.-O., Herian U., Theilmann L., and Bartenschlager R. Science 285 (1999) 110